Alvarez-Belon Lucas, Sarnowski Alexander, Forni Lui G
Intensive Care Unit, Royal Surrey Hospital Foundation Trust, Guildford, UK.
Renal Unit, St George's Hospital, London, UK.
Br J Hosp Med (Lond). 2020 Oct 2;81(10):1-8. doi: 10.12968/hmed.2020.0574. Epub 2020 Oct 6.
Despite initial reports, renal involvement, including acute kidney injury, has emerged as a serious complication of COVID-19 disease, particularly in critically ill patients. The reported prevalence varies considerably, which may reflect reporting practices, although differences in pre-existing comorbidities and socioeconomic factors, and differences between ethnic groups, almost certainly contribute. Renal involvement may present as an active urinary sediment or as changes in serum creatinine levels and urine output leading to acute kidney injury. In common with acute kidney injury complicating critical illness, the cause is often multifactorial and often presents as part of a multiorgan dysfunction syndrome. Treatment is, in the main, supportive, with kidney replacement therapy required in nearly 25% of reported cases. Few data currently exist as to the long-term burden of COVID-19-associated acute kidney injury but evidence suggests that only approximately one-third of patients are discharged with recovered renal function.
尽管有初步报告,但肾脏受累,包括急性肾损伤,已成为新冠病毒疾病的一种严重并发症,尤其是在危重症患者中。报告的患病率差异很大,这可能反映了报告方式,尽管既往合并症和社会经济因素的差异以及种族群体之间的差异几乎肯定也有影响。肾脏受累可能表现为活跃的尿沉渣,或血清肌酐水平和尿量的变化导致急性肾损伤。与危重症并发的急性肾损伤一样,病因通常是多因素的,且常表现为多器官功能障碍综合征的一部分。主要治疗方式为支持治疗,近25%的报告病例需要肾脏替代治疗。目前关于新冠病毒相关急性肾损伤的长期负担的数据很少,但有证据表明,只有约三分之一的患者出院时肾功能恢复正常。